Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research interests include Viral-associated cancers and disorders, Lymphoma Diagnosis and Treatment, Cytomegalovirus and herpesvirus research, and Parvovirus B19 Infection Studies.
Epstein–Barr virus induces aberrant B cell migration and diapedesis via FAK-dependent chemotaxis pathways
Epstein–Barr virus lytic replication and cancer
Predictors of Postviral Symptoms Following Epstein-Barr Virus-Associated Infectious Mononucleosis in Young People – Data from the IMMUC Study
Epstein-Barr virus infectious particles initiate B cell transformation and modulate cytokine response
Chronic Active Epstein-Barr Virus (EBV) Infection Controlled by Allogeneic Stem Cell Transplantation and EBV-Specific T Cells
BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1
Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy
PD-1 Blockade Aggravates Epstein–Barr Virus+ Post-Transplant Lymphoproliferative Disorder in Humanized Mice Resulting in Central Nervous System Involvement and CD4+ T Cell Dysregulations
Metagenomic analysis of primary colorectal carcinomas and their metastases identifies potential microbial risk factors
The Epstein–Barr virus noncoding RNA EBER2 transactivates the UCHL1 deubiquitinase to accelerate cell growth
Immunoinformatic Analysis Reveals Antigenic Heterogeneity of Epstein-Barr Virus Is Immune-Driven
Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection
Identification and Cloning of a New Western Epstein-Barr Virus Strain That Efficiently Replicates in Primary B Cells
A single phosphoacceptor residue in BGLF3 is essential for transcription of Epstein-Barr virus late genes
Spontaneous lymphoblastoid cell lines from patients with Epstein-Barr virus infection show highly variable proliferation characteristics that correlate with the expression levels of viral microRNAs
Correction: Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency
Herpesvirus deconjugases inhibit the IFN response by promoting TRIM25 autoubiquitination and functional inactivation of the RIG-I signalosome
Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in mice
Translational profiling of B cells infected with the Epstein-Barr virus reveals 5′ leader ribosome recruitment through upstream open reading frames
Epstein–Barr virus strain heterogeneity impairs human T-cell immunity
Epstein-Barr Virus Induces Expression of the LPAM-1 Integrin in B Cells <i>In Vitro</i> and <i>In Vivo</i>
Antibodies conjugated with viral antigens elicit a cytotoxic T cell response against primary CLL ex vivo
Abstract 3098: Promotion of in vivo growth of Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma by miR-BARTs
Antigen-armed antibodies against B-cell malignancies
Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression
Epstein–Barr virus particles induce centrosome amplification and chromosomal instability
Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency
Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential
PD-1/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse Model